跳至主要内容
临床试验/NL-OMON32874
NL-OMON32874招募中不适用

Clinical evaluation of a new sweat test system in the diagnosis of cystic fibrosis after newborn screening - The nanoduct study

Atrium Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • Newborns referred to the hospital for a sweat test after newborn screening. Children aged less than 2 months with a suspected diagnosis of Cystic Fibrosis. Informed consent has been obtained from the parents.

排除标准

  • Newborns with severe eczema, sepsis or dehydration (sweat test results are not reliable). Infants with meconium ileus. Informed consent can not be obtained.

研究者

发起方
Atrium Medisch Centrum

相似试验